Honest expectations are important: Green tea alone does not make you slim
GLP-1s were associated with lower risk of complications for those already having a substance use disorder Among people who already had a substance use disorder, starting a GLP-1 medication was associated with fewer substance-related emergency department visits, hospital admissions, overdose events, episodes of suicidal ideation or attempts, and lower mortality (see graph below)
Compounded Semaglutide and Tirzepatide: Safety Concerns FDA enforcement discretion policies during drug shortages have allowed compounding pharmacies to prepare semaglutide and tirzepatide products when commercial supplies were insufficient
Tirzepatide stability depends on proper storage conditions, which grey market products may not receive during manufacturing, shipping, or storage
Quick Answer: The FDA approves three equally appropriate sites for tirzepatide injection: the abdomen, thigh, and upper arm, with selection based on patient preference and practical considerations